Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

 

 

Ablavar (gadofosveset trisodium) is a contrast agent that produces magnetic effects. Doctors use the agent in combination with magnetic resonance angiography (MRA) and magnetic resonance imagery (MRI) to allow blood vessels, organs, and other non-bony tissues for scans. The FDA approved Ablavar in 1984.

 

Ablavar Dangers

AblavarUnfortunately, many people develop an allergic reaction to the Ablavar. The signs of this can be hives, difficulty breathing, and swelling of the face, lips, tongue, or throat.

Other warning signs are:

  • Urinating less than usual or not at all
  • Drowsiness, confusion, mood changes, increased thirst, loss of appetite
  • Swelling, weight gain, feeling short of breath
  • Fast, uneven heart rate

 

Ablavar Brain Deposits

Last year, the FDA reviewed reports of adverse health effects from Ablavar retained in the brain. The agency examined human and animal studies from contrast dye use over periods longer than a year. These publications and reports show that gadolinium like Ablavar is retained in organs such as the brain, bones, and skin. Symptoms of this are bone pain, burning skin pain, chemo brain, skin changes, skin thickening or discoloration.

 

Then, the FDA ordered “black-box” warnings for all gadolinium-based contrast agents like Ablavar.  A “black-box” warning is the strongest warning. It is designed to alert physicians of possible severe kidney damage in at-risk patients. In addition to kidney patients, the warning also extends to patients with chronic liver disease, including those just before or after liver transplantation. The FDA recommends that doctors screen patients for kidney problems prior to receiving a gadolinium-based imaging agent.

 

Free Case Evaluation

AblavarA gadolinium lawsuit may be an option for patients suffering from gadolinium retention and related complications. Gadolinium, used in dyes to increase the clarity of MRI and MRA scans, can create chemical element retention in the body, Therefore, this increases the risk of gadolinium deposition disease and nephrogenic systemic fibrosis. These conditions are accompanied by symptoms that include severe physical pain and cognitive difficulties. Affected patients and their loved ones may be able to file a lawsuit and recover damages.

 

Therefore, for more information, contact The Michael Brady Lynch Firm. We offer free, confidential, no-obligation consultations. We have over 20 years experience helping consumers injured by unsafe products manufactured by large companies.

×
What Our Clients Are Saying